Issue | Title | Abstract | File |
No 7-8 (2019) | Priority needs in creating restricted drug lists in Russia. Feasible approach | Abstract |
(Rus) |
Kolbin A.S., Maksimkina E.A., Mishinova S.A. | |||
No 3 (2018) | Problema ozhireniya: vzglyad spetsialista | Abstract |
(Rus) |
Article E. | |||
No 4 (2021) | Problems of theory and law enforcement practice of realization medicines to juveniles | Abstract | |
Zanina I.A., Soboleva A.M., Bolgov A.S. | |||
No 1-3 (2020) | Proizvodstvo meditsinskoy produktsii za 2019 god | Abstract |
(Rus) |
Article E. | |||
No 3 (2021) | Proizvodstvo meditsinskoy produktsii za aprel' 2021 goda | Abstract |
(Rus) |
- -. | |||
No 2 (2021) | Proizvodstvo meditsinskoy produktsii za fevral' 2021 goda | Abstract |
(Rus) |
- -. | |||
No 2 (2021) | Proizvodstvo meditsinskoy produktsii za mart 2021 goda | Abstract |
(Rus) |
- -. | |||
No 3 (2021) | Proizvodstvo meditsinskoy produktsii za may 2021 goda | Abstract |
(Rus) |
- -. | |||
No 9 (2020) | Proizvodstvo meditsinskoy produktsii za pervoe polugodie 2020 goda | Abstract |
(Rus) |
Article E. | |||
No 6 (2018) | Proizvodstvo otdel'nykh grupp meditsinskikh izdeliy za aprel' 2018 g | Abstract |
(Rus) |
Article E. | |||
No 10 (2018) | Proizvodstvo otdel'nykh grupp meditsinskikh izdeliy za avgust 2018 g | Abstract |
(Rus) |
Article E. | |||
No 1-2 (2018) | Proizvodstvo otdel'nykh grupp meditsinskikh izdeliy za dekabr' 2017 g | Abstract |
(Rus) |
Article E. | |||
No 3 (2019) | Properties of the two one-sided tests procedure for the bioequivalence assessment of medicinal products | Abstract |
(Rus) |
Dranitsyna M.A., Zakharova T.V., Niyazov R.R. | |||
No 4-6 (2020) | Prospects for further development of biobanks and genetic research: ethical implications | Abstract |
(Rus) |
Nadelyaeva I.I. | |||
No 7-8 (2018) | Protected dosage forms: foreign experience and prospects for introducing regulation in Russia | Abstract |
(Rus) |
Borzova M. | |||
No 10 (2018) | Protecting personal data respecting patients' privacy | Abstract |
(Rus) |
Volskaya E., Aleksandrova O. | |||
No 4 (2022) | Psychological attitude for a healthy lifestyle among workers of an industrial enterprise: the experience of an empirical study | Abstract |
(Rus) |
Bonkalo T.I., Ananchenkova P.I. | |||
No 9 (2020) | Public procurement during coronavirus pandemic. Review of tender purchases of J05 Direct-acting antivirals under FZ-44 and FZ-223 | Abstract |
(Rus) |
Kalinina N. | |||
No 7-8 (2018) | Quadrivalent influenza vaccines: an opportunity to reduce the influenza burden | Abstract |
(Rus) |
Kaplya-Bubenets V. | |||
No 4 (2022) | Quality of life in patients with novel coronavirus infection: association with disease severity and change depending on rehabilitation regimens after inpatient treatment | Abstract |
(Rus) |
Romanov A.O., Arkhangelskaya A.N., Sharipova M.M., Gurevich K.G. | |||
No 11 (2019) | Quantitative of the Russian pharmaceutical manufacturers and their classification | Abstract |
(Rus) |
Trofimova E.O., Yasinskaya L.E. | |||
No 6 (2019) | Quarterly judicial review pertaining to the production and circulation of medical products for February - April 2019 | Abstract |
(Rus) |
Borzova M. | |||
No 9 (2019) | Quarterly judicial review pertaining to the production and circulation of medical products for May - July 2019 | Abstract |
(Rus) |
Borzova M. | |||
No 3 (2019) | Quarterly judicial review pertaining to the production and circulation of medical products for November 2018 - February 2019 | Abstract |
(Rus) |
Borzova M. | |||
No 9 (2018) | Quarterly review of judicial practice in the sphere of manufacturing and circulation of medical products (may - august 2018) | Abstract |
(Rus) |
Borzova M. | |||
No 6 (2019) | Quaterly overview of the medical device market: current state and prospects of development of the russian suture filament market | Abstract |
(Rus) |
Vanin A. | |||
No 12 (2018) | Quaterly overview of the medical device market: current state and prospects of the Russian market for nonwovens and kits - needles and syringes | Abstract |
(Rus) |
Vanin A. | |||
No 1 (2022) | Rare diseases in the subjects of the Russian Federation: are these patients rare? | Abstract | |
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y. | |||
No 3 (2019) | Rasseyannyy skleroz - «diagnoz isklyucheniya». Interv'yu s Alekseem Boyko | Abstract |
(Rus) |
Article E. | |||
No 12 (2018) | Rasseyannyy skleroz: ot kontrolya simptomov k otsutstviyu retsidivov | Abstract |
(Rus) |
Litvak N. | |||
No 11 (2019) | Rating of pharmaceutical companies by return on equity in 2017 | Abstract |
(Rus) |
Romanova S. | |||
No 5 (2018) | Rational contraception as part of the national strategy | Abstract |
(Rus) |
Prozherina J. | |||
No 6 (2018) | Rational drug therapy of ulcerative colitis: meta-analysis and clinical and economic aspects of modern therapy regimens | Abstract |
(Rus) |
Shatalova O.V., Gorbatenko V.S. | |||
No 7-8 (2018) | Razvivat' biznes, razvivaya otrasl' | Abstract |
(Rus) |
Shirokova I. | |||
No 4-6 (2020) | Redkie i ochen' dorogie: o slozhnostyakh lekarstvennogo obespecheniya patsientov s orfannymi zabolevaniyami | Abstract |
(Rus) |
Kuminova E. | |||
No 7-8 (2019) | Registratsiya rossiyskogo preparata dlya lecheniya virusnogo gepatita D | Abstract |
(Rus) |
Article E. | |||
No 7-8 (2018) | Regulatory aspects of marketing authorization of generic and hybrid medicinal products in the Eurasian Economic Union | Abstract |
(Rus) |
Niyazov R.R., Rozhdestvenskiy D.A., Vasiliev A.N., Gavrishina E.V., Dranitsyna М.А., Kulichev D.A. | |||
No 10 (2018) | Regulatory aspects of the introduction of the drug therapy outcomes-based payment concept | Abstract |
(Rus) |
Tolkushin A.G., Fedorov A.A., Yagudina R.I., Davydovskaya M.V., Chernitskaya M.K., Ermolaeva T.N., Kobzeva N.V., Kokushkin K.A. | |||
No 4 (2021) | Regulatory legal framework for immunoprophylaxis in the CIS member states | Abstract | |
Putilo N.V. | |||
No 3 (2022) | Reproductive technologies in solving the problems of infertility of the population (Part I) | Abstract |
(Rus) |
Tliashinova I.A., Sadykova R.N., Mingazova E.N. | |||
No 4 (2022) | Reproductive technologies in solving the problems of infertility of the population (Part II) | Abstract |
(Rus) |
Tliashinova I.A., Sadykova R.N., Mingazova E.N. | |||
No 2 (2021) | Reproduktivnoe zdorov'e zhenshchiny: sovremennye realii | Abstract |
(Rus) |
- -. | |||
No 7-8 (2020) | Research into the causes of conflicts in a pharmacy organization | Abstract |
(Rus) |
Safronova Z.S. | |||
No 4 (2018) | Responsible self - management is a conscious approach to health | Abstract |
(Rus) |
Kaplya-Bubenets V... | |||
No 10 (2019) | Retail sector of the pharmaceutical market of the Russian Federation: regional characteristics analysis | Abstract |
(Rus) |
Petrukhina I.K., Yagudina R.I., Ryazanova T.K., Khusainova A.I., Egorova A.V. | |||
No 2 (2022) | Retrospective analysis of the organization of sanitary and educational activities of pharmacy organizations in the USSR | Abstract |
(Rus) |
Shestakova T.V. | |||
No 13S (2018) | Review of cosmetics sales in pharmacies: 2017 results | Abstract |
(Rus) |
Nechaeva J. | |||
No 3 (2019) | Review of Federal medicine assistance schemes | Abstract |
(Rus) |
Kovaleva K.A., Narkevich I.A., Nemyatykh .D., Vasyagina Y.A. | |||
No 9 (2020) | Review of pharmacy sales of plasters and self-adhesive dressings | Abstract |
(Rus) |
Nechaeva Y. | |||
No 3 (2019) | Review of PIC/S guidance on classification of GMP deficiencies | Abstract |
(Rus) |
Orlov V.A. | |||
No 10 (2019) | Review of the Russian pharmaceutical market: results of the 1st half of 2019 | Abstract |
(Rus) |
Kalinina N. | |||
No 1 (2021) | Reyting aptechnykh setey Rossii po itogam 2020 goda | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 2 (2021) | Reyting aptechnykh setey Rossii po itogam I kvartala 2021 goda | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 3 (2021) | Reyting aptechnykh setey Rossii po itogam I–II kv. 2021 goda | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 7-8 (2020) | Reyting aptechnykh setey Rossiipo itogam 1-go polugodiya 2020 goda | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 7-8 (2020) | Rezervy polnogo tsikla | Abstract |
(Rus) |
Kuminova E. | |||
No 4 (2018) | Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia | Abstract |
(Rus) |
Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A. | |||
No 2 (2022) | Risks in the lifestyle of students | Abstract |
(Rus) |
Gureev S.A., Mingazov R.N., Sadykova R.N., Shegurova K.A. | |||
No 11 (2018) | Road map and BAA market: forecasts and risks | Abstract |
(Rus) |
Borzova M. | |||
No 5 (2019) | Rossiya stanet odnoy iz pervykh stran, pristupivshikh k primeneniyu innovatsionnoy vaktsiny protiv gepatita B | Abstract |
(Rus) |
Article E. | |||
No 1-2 (2019) | Rossiyskaya kompaniya nauchila neyroset' iskat' metastazy | Abstract |
(Rus) |
Article E. | |||
No 4 (2019) | Rossiyskie vaktsiny otsenili mezhdunarodnye eksperty | Abstract |
(Rus) |
ShIROKOVA I. | |||
No 11-12 (2020) | Rossiyskiy farmatsevticheskiy forum o rasshirenii perechnya ZhNVLP | Abstract |
(Rus) |
Kuminova E. | |||
No 10 (2019) | Rossiyskiy rynok implantov dlya osteosinteza | Abstract |
(Rus) |
Vanin A. | |||
No 10 (2019) | Rossiyskiy rynok rastet blagodarya gossegmentu | Abstract |
(Rus) |
Shirokova I. | |||
No 1-2 (2018) | Russia builds the future without tobacco | Abstract |
(Rus) |
Prozherina J., Shirokova I. | |||
No 12 (2019) | Russia: export of FPPs at аugust-end 2019 | Abstract |
(Rus) |
- -. | |||
No 12 (2019) | Russia: import of FPPs at аugust-end 2019 | Abstract |
(Rus) |
- -. | |||
No 3 (2021) | Russian marketing analysis of biologically active additives with pancreatic enzyme | Abstract |
(Rus) |
Narkevich I.A., Nemyatykh O.D., Basakina I.I., Fitisova A.I. | |||
No 4-6 (2020) | Russian pharma distributors rating at year-end 2019 | Abstract |
(Rus) |
Nechaeva Y. | |||
No 2 (2021) | Russian pharmaceutical market as of the first quarter, 2021 | Abstract |
(Rus) |
Kalinina N., Shestovets A. | |||
No 1 (2021) | Russian pharmaceutical market at the end of 2020 | Abstract |
(Rus) |
Kazova A., Kalinina N. | |||
No 5 (2018) | Russian pharmaceutical market at the first quarter-end 2018 | Abstract |
(Rus) |
Denisova M., Prozerina J. | |||
No 1-3 (2020) | Russian Pharmaceutical Market in 2019 | Abstract |
(Rus) |
Kalinina N. | |||
No 13S (2018) | Russian pharmaceutical market: results and forecasts | Abstract |
(Rus) |
Article E. | |||
No 3 (2019) | Russian pharmacovigilance in a newly regulated environment: two-year results and prospects | Abstract |
(Rus) |
Glagolev S.V., Gorelov K.V., Chizhova D.A. | |||
No 10 (2020) | Russian pharmacy chains ranking based on the results for I-III Q 2020 | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 5 (2018) | Rynok truda - adaptatsiya k novym vyzovam | Abstract |
(Rus) |
Shirokova I. | |||
No 10 (2019) | Samyy moshchnyy v mire apparat MRT | Abstract |
(Rus) |
Article E. | |||
No 12 (2018) | Saturate the domestic market with quality products | Abstract |
(Rus) |
Prozherina J., Shirokova I. | |||
No 3 (2022) | Scientific substantiation of the possibility of integrated interagency management in countering global biorisks for public health (by the example of the COVID-19 pandemic) | Abstract |
(Rus) |
Kaunina D.V., Vasilyev M.D. | |||
No 13S (2018) | Segment of regional reimbursement programs | Abstract |
(Rus) |
Article E. | |||
No 12 (2018) | Sergey Akopov: «Soteks» - primer sotsial'no otvetstvennogo biznesa | Abstract |
(Rus) |
Akopov S. | |||
No 3 (2018) | Sergey Illarioshkin: «Bolezn' Parkinsona - eto sotsial'nyy vyzov obshchestvu i meditsine» | Abstract |
(Rus) |
Article E. | |||
No 4-6 (2020) | Server lights. Rating of Russian pharmacy chains according to the Q1 2020 results | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 1-3 (2020) | Silicon raspberries. Russian pharmacy chains rating at year-end 2019 | Abstract |
(Rus) |
Bespalov N., Rasshchupkin P. | |||
No 9 (2020) | Sistema MDLP perevoditsya na uvedomitel'nyy rezhim raboty | Abstract |
(Rus) |
Article E. | |||
No 1 (2021) | Smart glucometers: revolution in diabetes management | Abstract |
(Rus) |
Prozherina Y. | |||
No 4 (2021) | Socio-medical aspects of dental prosthetics of elderly patients who have had COVID-19 | Abstract | |
Kopytov A.A., Volkova O.A., Ovchinnikov I.V. | |||
No 4 (2019) | SOGLAShENIE O LOKALIZATsII V ROSSII PROIZVODSTVA TEST-SISTEMY DLYa DIAGNOSTIKI TUBERKULEZA | Abstract |
(Rus) |
- -. | |||
No 10 (2018) | Sokhranit' ostrotu zreniya | Abstract |
(Rus) |
Bykovchenko I. | |||
No 4 (2021) | Some aspects of the activities of the center for hygiene and epidemiology in Kazan from 2012 to 2019 | Abstract | |
Khuzikhanov F.V., Nigmatzyanova R.R. | |||
No 1-2 (2018) | Sovremennaya strategiya vizualizatsii v meditsine: issledovat', izobretat', transformirovat' | Abstract |
(Rus) |
Khitrov A. | |||
No 9 (2019) | Sovremennye tekhnologii izmenyayut prognoz bol'nykh s insul'tom. Interv'yu s Mikhailom Piradovym | Abstract |
(Rus) |
Article E. | |||
No 4-6 (2020) | Speaking in support of patients with HIV-infection | Abstract |
(Rus) |
Prozherina Y., Shirokova I. | |||
No 4 (2018) | Special investment contracts: reload or retuning? | Abstract |
(Rus) |
Tarasova D., Oganesyan A., Lobanov R. | |||
No 6 (2018) | State policy in the sphere of pharmaceutics in the USSR in the 1930s | Abstract |
(Rus) |
Sherstneva E.V. | |||
No 1-2 (2018) | State regulation of prices on medicines: search for balance | Abstract |
(Rus) |
Kopytin D.A. | |||
No 3 (2021) | State support of export for enterprises of the medical and pharmaceutical industry | Abstract |
(Rus) |
Gertsik Y.G. | |||
No 6 (2018) | Sterilizatsionnoe i dezinfektsionnoe oborudovanie STEELCO i «Farmstil» - garantiya i kachestvo | Abstract |
(Rus) |
Shirokova I. | |||
401 - 500 of 611 Items | << < 1 2 3 4 5 6 7 > >> |